The expression of NOP56 is significantly upregulated in acute myeloid leukemia, diffuse large B-cell lymphoma, and Myc-mutant Burkitt’s lymphoma, and may also be associated with poorer prognosis (7–9). Here, MYC is linked to Burkitt lymphoma.